Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call
24 January 2012 - 8:05AM
Business Wire
Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) will release its
fourth quarter and full year 2011 financial results on Tuesday,
February 21, 2012, after the market closes. The earnings news
release will be available on the Furiex website at
www.furiex.com.
On Wednesday, February 22, 2012, at 9 a.m. ET, Furiex will
conduct a live conference call and audio webcast to discuss
financial results and product portfolio. A Q&A session will
follow. The conference call will be broadcast live over the
Internet and will also be available using the following direct dial
numbers:
Participant dial-in: +1 877 267 0934
(U.S./Canada) +1 706 643 0961 (International) Conference ID:
45542437
All interested parties can access the webcast through the
Presentations & Events link in the Investors section of the
Furiex website at www.furiex.com. The webcast will be archived
shortly after the call for on-demand replay.
About Furiex
Furiex Pharmaceuticals is a drug development collaboration
company that uses innovative clinical development design to
accelerate and increase value of internal and partnered drug
programs by advancing them through the drug discovery and
development process in a cost-efficient manner. Development
programs are designed and driven by a core team with extensive drug
development experience. The company collaborates with
pharmaceutical and biotechnology companies and has a strong,
diversified product portfolio and pipeline with multiple
therapeutic candidates including late-stage assets and two products
on the market. The company's mission is to develop innovative
medicines faster and at a lower cost, thereby improving
profitability and accelerating time to market while providing
life-improving therapies for patients. For more information, visit
www.furiex.com.
(MM) (NASDAQ:FURX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:FURX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Furiex Pharmaceuticals, Inc. News Articles